BioCentury
ARTICLE | Strategy

Numerate’s Intelligence

How Numerate’s AI tackles translational questions with tiny data sets

September 14, 2017 11:34 PM UTC

With three new partnerships formed since June, Numerate Inc. is picking up steam and demonstrating that industry and academic groups alike are finding utility in its AI platform, which can build robust predictive models for preclinical development using the tiniest of data sets.

According to President and CEO Guido Lanza, the primary feature that sets Numerate apart from other artificial intelligence (AI) companies is that it is not dependent on accessing large mountains of data...